Table 1.
Summary of baseline characteristics of study patients (n = 34)
| N = 34 | |
| Age (median, interquartile range) | 63 (IQR 56-66) |
| Male % | 2 |
| Current smoking % | 50 |
| Family history of premature coronary artery disease % | 29 |
| Hypertension % | 29 |
| Hypercholesterolaemia % | 35 |
| Diabetes % | 9 |
| Infarct-related artery % | |
| Left anterior descending artery | 32 |
| Left circumflex artery | 24 |
| Right coronary artery | 44 |
| Primary percutaneous coronary intervention (PPCI) % | 100 |
| TIMI flow post-PCI % | |
| TIMI 3 | 85 |
| TIMI 2 | 15 |
| TIMI1 | 0 |
| Use of Glycoprotein 2b/3a inhibitors % | 53 |
| Use of Bivalirudin % | 47 |
| Use of percutaneous thrombectomy device % | 21 |